Madrigal Pharmaceuticals, Inc. Board of Directors

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.

Mr. William J. Sibold

Mr. William J. Sibold

CEO, President & Director

Ms. Shannon Kelley

Ms. Shannon Kelley

Chief Compliance Office & General Counsel

Mr. Ronald Filippo

Mr. Ronald Filippo

Chief Information Officer

Dr. Rebecca A. Taub M.D.

Dr. Rebecca A. Taub M.D.

Founder, Chief Medical Officer, President of Research & Development and Director

Mr. Clint Wallace

Mr. Clint Wallace

Chief Human Resources Officer

Ms. Carole Huntsman

Ms. Carole Huntsman

Chief Commercial Officer

Ms. Tina E. Ventura

Ms. Tina E. Ventura

Chief Investor Relations Officer

Mr. Mark Underwood

Mr. Mark Underwood

Senior Vice President of Business Planning & Operations

Mr. Edward Chiang

Mr. Edward Chiang

Senior Vice President of Clinical & Technical Operations

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.